Immuneering Corp - IMRX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Chief Financial Officer | A | A | 650,000.0 | 0.0 | 0.0 | 650,000.0 | View | |
| Jun 24, 2026 | PRESIDENT AND CEO | P | A | 2,400.0 | 4.5617 | 10,948.08 | 2,315,252.0 | View | |
| Jun 16, 2026 | CHIEF SCIENTIFIC OFFICER | P | A | 6,035.0 | 4.15 | 25,045.25 | 382,531.0 | View | |
| Jun 11, 2026 | — | A | A | 33,350.0 | 0.0 | 0.0 | 33,350.0 | View | |
| Jun 11, 2026 | — | A | A | 33,350.0 | 0.0 | 0.0 | 33,350.0 | View | |
| Jun 11, 2026 | — | A | A | 33,350.0 | 0.0 | 0.0 | 33,350.0 | View | |
| Jun 11, 2026 | — | A | A | 33,350.0 | 0.0 | 0.0 | 33,350.0 | View | |
| Jun 11, 2026 | — | A | A | 33,350.0 | 0.0 | 0.0 | 33,350.0 | View |